Notice of Results

RNS Number : 9779Q
Hutchison China Meditech Limited
26 June 2020
 

Chi-Med to Announce 2020 Half-Year Financial Results

 

London: Friday, June 26, 2020: Hutchison China MediTech Limited ("Chi-Med") (Nasdaq/AIM: HCM) will be announcing its interim results for the six months ended June 30, 2020 on Thursday, July 30 , 2020 at 12:00 noon British Summer Time (BST) (7:00 pm Hong Kong Time (HKT); 7:00 am Eastern Daylight Time (EDT)).

 

Analysts and investors are invited to join a conference call and audio webcast presentation with Q&A, conducted by Chi-Med management. 

 

The conference call and audio webcast will take place at 1:00 pm BST / 8:00 pm HKT / 8 :00 am EDT on Thursday, July 30, 2020 and will be webcast live via the company website at www.chi-med.com/investors/event-information/ .  The presentation will be available for downloading before the conference call begins. Details of the conference call dial-in will be provided in the financial results announcement and on the company website.   A replay will also be available on the website shortly after the event.

 

 

About Chi-Med

 

Chi-Med (Nasdaq/AIM: HCM) is an innovative biopharmaceutical company committed, over the past twenty years, to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.  It has a portfolio of eight cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. For more information, please visit: www.chi-med.com .

 

 

CONTACTS

 

Investor Enquiries


Mark Lee, Senior Vice President

+852   2121   8200

Annie Cheng, Vice President

+1   (973)   567   3786



Media Enquiries


Americas - Brad Miles, Solebury Trout

+1   (917)   570   7340   (Mobile) 
bmiles@troutgroup.com

Europe - Ben Atwell / Alex Shaw, FTI Consulting

+44   20   3727   1030 / +44   7771   913   902   (Mobile) / +44 7779 545 055 (Mobile)
Chi-Med@fticonsulting.com

Asia - Joseph Chi Lo / Zhou Yi, Brunswick

+852   9850   5033 (Mobile), jlo@brunswickgroup.com / +852   97 83   6894 (Mobile), y zhou@brunswickgroup.com



Nominated Advisor


Freddy Crossley / Atholl Tweedie, Panmure Gordon (UK) Limited

+44   (20)   7886   2500

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORDZGZVDDGGGZM
UK 100

Latest directors dealings